Clinical Trials Directory

Trials / Completed

CompletedNCT00447967

Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients

A Randomized Phase II Study of Irinotecan and Oxaliplatin Versus the Combination of 5-FU/LV and Oxaliplatin, as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
110 (estimated)
Sponsor
Hellenic Oncology Research Group · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This phase II trial will compare the efficacy and toxicity of the combination of Irinotecan and Oxaliplatin versus 5-FU/LV and Oxaliplatin as first line treatment in patients with locally advanced or metastatic gastric cancer

Detailed description

There is no regimen considered standard in advanced gastric cancer. The reported response rates of 5-FU-based combination chemotherapy are higher than single agents (10-50%) but more toxic. The combination of 5-FU/LV and LOHP has demonstrated an ORR of 43%, median TTP of approximately 6,5 months and OS of 8,6 months in phase II trials, with an acceptable toxicity. Irinotecan (CPT-11) is effective as salvage treatment in metastatic gastric cancer and has a synergistic activity with LOHP in preclinical trials

Conditions

Interventions

TypeNameDescription
DRUGIrinotecanIrinotecan 200 mg/m2 IV on Day 1 every 3 weeks for 6 cycles
DRUGOxaliplatinOxaliplatin 80 mg/m2 IV on Day 2 every 3 weeks for 6 cycles
DRUGFluorouracilFluorouracil 400 mg/m2 infused over 10 min IV and Fluorouracil600 mg/m2 infused over 22 hours IV, Day 1 and 2 (De Grammont regimen)every 2 weeks for 12 cycles
DRUGLeucovorinLeucovorin 200 mg/m2 infused over 1 hour IV on day 1 and day 2 (De Grammont regimen) every 2 weeks for 12 cycles
DRUGOxaliplatinOxaliplatin 85 mg/m2 as a 4 hour IV infusion, Day 1 every 4 weeks for 6 cycles

Timeline

Start date
2004-07-01
Primary completion
2008-09-01
Completion
2008-09-01
First posted
2007-03-15
Last updated
2009-09-28

Locations

8 sites across 1 country: Greece

Source: ClinicalTrials.gov record NCT00447967. Inclusion in this directory is not an endorsement.